17 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ClearTip

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

BD BBL™ Sensi-Disc™ Bacitracin 2 units

FDA UDI
BECTON, DICKINSON AND COMPANY·30382902312674·BD BBL™ Sensi-Disc™ Bacitracin 2 units

Dornier MedTech

FDA UDI
DORNIER MEDTECH AMERICA, INC.·00810116022700·Dornier 400 µm Single-Use SMA Diode Laser Fiber...

Sklar®

FDA UDI
SKLAR CORPORATION·10649111162831·SKLARCUT SKLARLITE METZ CVD 7"

STERICHEK BICARB PH REAGENT STRIPS

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

VOLUSON E6/E8/E8EXPERT/E8EXPERT LIMITED EDITION/E10

FDA 510(k)
FDA Class 2 ·Radiology

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

FDA Adverse Event
Injury ·MEDTRONIC MINIMED·Product code OYC·November 6, 2014

HOMECHOICE AUTOMATED PD SET WITH CASSETTE

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - MOUNTAIN HOME·Product code FKX·September 1, 2011

LOCK-CAP ONE-STEP F/MATRIX 5.5 TAN

FDA Adverse Event
Malfunction ·SYNTHES BRANDYWINE·Product code NKB·July 17, 2013

UNSPECIFIED BD VACUTAINER® SODIUM FLUORIDE/POTASSIUM OXALATE TUBES

FDA Adverse Event
Malfunction ·BECTON DICKINSON & CO (FRANKLIN LAKES)·Product code JKA·October 15, 2025

BD VACUTAINER® SODIUM FLUORIDE/POTASSIUM OXALATE 5MG/4MG

FDA Adverse Event
Malfunction ·BECTON, DICKINSON & CO. (BROKEN BOW)·Product code JKA·May 23, 2024

CARTO 3

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DQK·September 16, 2024

CARTO® 3 SYSTEM

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DQK·May 21, 2024

CARTO 3

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DQK·October 28, 2025

CARTO® 3 SYSTEM

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DQK·April 17, 2024

CARTO 3

FDA Adverse Event
Malfunction ·BIOSENSE WEBSTER INC·Product code DQK·October 15, 2025

Model Number L111, ESSENTIO DR SL MRI Pacemaker

FDA Enforcement
Class I ·Ongoing·Boston Scientific Corporation·October 22, 2025